Trial Profile
Efficacy of Ozurdex in the Treatment of Diabetic Macular Edema (DME)
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 14 Jul 2023
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- Acronyms Louvre 3
- Sponsors Allergan
- 26 Mar 2023 Results (n= 112) of short-term outcomes of LOUVRE 3 study, published in the Ophthalmology and Therapy.
- 21 Nov 2017 Status changed from not yet recruiting to recruiting.
- 20 Jul 2017 Planned End Date changed from 1 Sep 2019 to 15 Apr 2020.